ApprovalTrail

Approval · Notice of Compliance 26586 · 2021

APO-ACYCLOVIR: Notice of Compliance 26586

Issued September 2, 2021

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
26586
Date
September 2, 2021
Company
Apotex Inc.Toronto, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Admin
Reason
Administrative: Labelling Update (to Match Licensor)

Products in this notice

BrandDINStatus today
APO-ACYCLOVIRNot yet assigned—

Medicinal ingredients